ID   SH3R1_HUMAN             Reviewed;         888 AA.
AC   Q7Z6J0; Q05BT2; Q8IW46; Q9HAM2; Q9P234;
DT   20-MAY-2008, integrated into UniProtKB/Swiss-Prot.
DT   22-JUL-2008, sequence version 2.
DT   10-MAY-2017, entry version 118.
DE   RecName: Full=E3 ubiquitin-protein ligase SH3RF1;
DE            EC=2.3.2.27;
DE   AltName: Full=Plenty of SH3s;
DE            Short=Protein POSH;
DE   AltName: Full=RING finger protein 142;
DE   AltName: Full=RING-type E3 ubiquitin transferase SH3RF1 {ECO:0000305};
DE   AltName: Full=SH3 domain-containing RING finger protein 1;
DE   AltName: Full=SH3 multiple domains protein 2;
GN   Name=SH3RF1; Synonyms=KIAA1494, POSH, RNF142, SH3MD2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 140-888 (ISOFORM 2).
RC   TISSUE=Eye, and Ovary;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-712 (ISOFORM 1).
RC   TISSUE=Embryo;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 251-888 (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=10819331; DOI=10.1093/dnares/7.2.143;
RA   Nagase T., Kikuno R., Ishikawa K., Hirosawa M., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XVII.
RT   The complete sequences of 100 new cDNA clones from brain which code
RT   for large proteins in vitro.";
RL   DNA Res. 7:143-150(2000).
RN   [4]
RP   INTERACTION WITH MAP3K10; MAP3K11; DLK1; MAP2K4; MAP2K7; MAPK8 AND
RP   MAPK9.
RX   PubMed=12514131; DOI=10.1093/emboj/cdg021;
RA   Xu Z., Kukekov N.V., Greene L.A.;
RT   "POSH acts as a scaffold for a multiprotein complex that mediates JNK
RT   activation in apoptosis.";
RL   EMBO J. 22:252-261(2003).
RN   [5]
RP   INTERACTION WITH AKT1 AND AKT2.
RX   PubMed=14504284; DOI=10.1074/jbc.M307357200;
RA   Figueroa C., Tarras S., Taylor J., Vojtek A.B.;
RT   "Akt2 negatively regulates assembly of the POSH-MLK-JNK signaling
RT   complex.";
RL   J. Biol. Chem. 278:47922-47927(2003).
RN   [6]
RP   FUNCTION AS AN E3 UBIQUITIN-PROTEIN LIGASE, FUNCTION IN HIV-1 PLASMA
RP   MEMBRANE TARGETING, SUBCELLULAR LOCATION, AND SELF-UBIQUITINATION.
RX   PubMed=15659549; DOI=10.1073/pnas.0408717102;
RA   Alroy I., Tuvia S., Greener T., Gordon D., Barr H.M., Taglicht D.,
RA   Mandil-Levin R., Ben-Avraham D., Konforty D., Nir A., Levius O.,
RA   Bicoviski V., Dori M., Cohen S., Yaar L., Erez O., Propheta-Meiran O.,
RA   Koskas M., Caspi-Bachar E., Alchanati I., Sela-Brown A., Moskowitz H.,
RA   Tessmer U., Schubert U., Reiss Y.;
RT   "The trans-Golgi network-associated human ubiquitin-protein ligase
RT   POSH is essential for HIV type 1 production.";
RL   Proc. Natl. Acad. Sci. U.S.A. 102:1478-1483(2005).
RN   [7]
RP   INTERACTION WITH SIAH1.
RX   PubMed=16230351; DOI=10.1074/jbc.M509060200;
RA   Xu Z., Sproul A., Wang W., Kukekov N., Greene L.A.;
RT   "Siah1 interacts with the scaffold protein POSH to promote JNK
RT   activation and apoptosis.";
RL   J. Biol. Chem. 281:303-312(2006).
RN   [8]
RP   INTERACTION WITH MAPK8IP.
RX   PubMed=16571722; DOI=10.1074/jbc.M601056200;
RA   Kukekov N.V., Xu Z., Greene L.A.;
RT   "Direct interaction of the molecular scaffolds POSH and JIP is
RT   required for apoptotic activation of JNKs.";
RL   J. Biol. Chem. 281:15517-15524(2006).
RN   [9]
RP   INTERACTION WITH AKT1 AND AKT2, PHOSPHORYLATION AT SER-304,
RP   MUTAGENESIS OF SER-304, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=17535800; DOI=10.1074/jbc.M704321200;
RA   Lyons T.R., Thorburn J., Ryan P.W., Thorburn A., Anderson S.M.,
RA   Kassenbrock C.K.;
RT   "Regulation of the pro-apoptotic scaffolding protein POSH by Akt.";
RL   J. Biol. Chem. 282:21987-21997(2007).
RN   [10]
RP   INTERACTION WITH HERP1, SUBCELLULAR LOCATION, AND MUTAGENESIS OF
RP   VAL-14.
RX   PubMed=17420289; DOI=10.1083/jcb.200611036;
RA   Tuvia S., Taglicht D., Erez O., Alroy I., Alchanati I., Bicoviski V.,
RA   Dori-Bachash M., Ben-Avraham D., Reiss Y.;
RT   "The ubiquitin E3 ligase POSH regulates calcium homeostasis through
RT   spatial control of Herp.";
RL   J. Cell Biol. 177:51-61(2007).
RN   [11]
RP   FUNCTION AS AN E3 UBIQUITIN-PROTEIN LIGASE.
RX   PubMed=19710010; DOI=10.1074/jbc.M109.041582;
RA   Lin D.H., Yue P., Pan C.Y., Sun P., Zhang X., Han Z., Roos M.,
RA   Caplan M., Giebisch G., Wang W.H.;
RT   "POSH stimulates the ubiquitination and the clathrin-independent
RT   endocytosis of ROMK1 channels.";
RL   J. Biol. Chem. 284:29614-29624(2009).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-304, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-304 AND SER-532, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: Acts as a scaffold protein, contributes to Rac-induced
CC       signal transduction such as JNKs (MAPK8 and MAPK9) activation and
CC       induces apoptosis. Within a signaling complex, it probably
CC       recruits protein kinases such as MAP3K10 or MAP3K11 which are in
CC       turn activated leading to the sequential activation of MAP2K4,
CC       MAP2K7 and JNKs (MAPK8 and MAPK9) (By similarity). May be involved
CC       in targeting of HIV-1 GAG and GAG-POL polyproteins to the plasma
CC       membrane. {ECO:0000250, ECO:0000269|PubMed:15659549,
CC       ECO:0000269|PubMed:19710010}.
CC   -!- FUNCTION: Might act as an E3 ubiquitin-protein ligase, or as part
CC       of E3 complex, which accepts ubiquitin from specific E2 ubiquitin-
CC       conjugating enzymes such as UBE2D1 or UBE2N and then transfers it
CC       to substrates. In the absence of an external substrate, it can
CC       catalyze self-ubiquitination. Stimulates ubiquitination of
CC       potassium channel KCNJ1, enhancing it's dynamin-dependent and
CC       clathrin-independent endocytosis.
CC   -!- FUNCTION: Plays an essential role in the targeting of HIV-1 Gag to
CC       the plasma membrane, this function is dependent on it's RING
CC       domain, and hence it's E3 ligase activity.
CC   -!- CATALYTIC ACTIVITY: S-ubiquitinyl-[E2 ubiquitin-conjugating
CC       enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-
CC       conjugating enzyme]-L-cysteine + N(6)-ubiquitinyl-[acceptor
CC       protein]-L-lysine.
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC   -!- SUBUNIT: Interacts with Rac; in a GTP-dependent manner (By
CC       similarity). Interacts with MAP3K10 and MAP3K11. Interacts with
CC       MAPK8IP; this interaction leads to the PJAC complex (POSH-JIP or
CC       SH3RF1/MAPK8IP apoptotic complex) with a 1:1 ratio. Interacts with
CC       SIAH1. Interacts with HERP1. Probably part of a signaling complex
CC       that may contain SH3RF1, MAPK8IP, DLK1, MAP2K4, MAP2K7, MAPK8,
CC       MAPK9, AKT1 and AKT2. {ECO:0000250, ECO:0000269|PubMed:12514131,
CC       ECO:0000269|PubMed:14504284, ECO:0000269|PubMed:16230351,
CC       ECO:0000269|PubMed:16571722, ECO:0000269|PubMed:17420289,
CC       ECO:0000269|PubMed:17535800}.
CC   -!- INTERACTION:
CC       P63000:RAC1; NbExp=2; IntAct=EBI-311339, EBI-413628;
CC       O43255:SIAH2; NbExp=2; IntAct=EBI-311339, EBI-948141;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, perinuclear region {ECO:0000250}.
CC       Cell projection, lamellipodium. Cytoplasm. Golgi apparatus, trans-
CC       Golgi network. Note=Colocalizes, with AKT2, in lamellipodia (By
CC       similarity). Colocalizes, with HERP1, in trans-Golgi network.
CC       {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q7Z6J0-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q7Z6J0-3; Sequence=VSP_033622, VSP_033623;
CC         Note=No experimental confirmation available.;
CC   -!- DOMAIN: The RING finger domain is responsible of ubiquitination
CC       and proteasomal degradation.
CC   -!- PTM: Phosphorylated at Ser-304 by AKT1 and AKT2. When
CC       phosphorylated, it has reduced ability to bind Rac.
CC       {ECO:0000269|PubMed:17535800}.
CC   -!- PTM: Subject to ubiquitination and proteasomal degradation.
CC       {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the SH3RF family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH33203.1; Type=Frameshift; Positions=182; Evidence={ECO:0000305};
CC       Sequence=AAH33203.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence.; Evidence={ECO:0000305};
CC       Sequence=AAH53671.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Sequence of unknown origin in the middle of the protein.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BC033203; AAH33203.1; ALT_SEQ; mRNA.
DR   EMBL; BC041023; AAH41023.1; -; mRNA.
DR   EMBL; BC053671; AAH53671.1; ALT_SEQ; mRNA.
DR   EMBL; AK021429; BAB13822.1; -; mRNA.
DR   EMBL; AB040927; BAA96018.1; -; mRNA.
DR   CCDS; CCDS34099.1; -. [Q7Z6J0-1]
DR   RefSeq; NP_065921.2; NM_020870.3. [Q7Z6J0-1]
DR   UniGene; Hs.301804; -.
DR   ProteinModelPortal; Q7Z6J0; -.
DR   SMR; Q7Z6J0; -.
DR   BioGrid; 121673; 18.
DR   DIP; DIP-31636N; -.
DR   IntAct; Q7Z6J0; 12.
DR   MINT; MINT-2792302; -.
DR   STRING; 9606.ENSP00000284637; -.
DR   iPTMnet; Q7Z6J0; -.
DR   PhosphoSitePlus; Q7Z6J0; -.
DR   BioMuta; SH3RF1; -.
DR   DMDM; 205830834; -.
DR   EPD; Q7Z6J0; -.
DR   MaxQB; Q7Z6J0; -.
DR   PaxDb; Q7Z6J0; -.
DR   PeptideAtlas; Q7Z6J0; -.
DR   PRIDE; Q7Z6J0; -.
DR   Ensembl; ENST00000284637; ENSP00000284637; ENSG00000154447. [Q7Z6J0-1]
DR   GeneID; 57630; -.
DR   KEGG; hsa:57630; -.
DR   UCSC; uc003isa.2; human. [Q7Z6J0-1]
DR   CTD; 57630; -.
DR   DisGeNET; 57630; -.
DR   GeneCards; SH3RF1; -.
DR   HGNC; HGNC:17650; SH3RF1.
DR   HPA; HPA074783; -.
DR   neXtProt; NX_Q7Z6J0; -.
DR   OpenTargets; ENSG00000154447; -.
DR   PharmGKB; PA134915904; -.
DR   eggNOG; ENOG410ITG6; Eukaryota.
DR   eggNOG; ENOG410XS5R; LUCA.
DR   GeneTree; ENSGT00760000119190; -.
DR   HOGENOM; HOG000045564; -.
DR   HOVERGEN; HBG069552; -.
DR   InParanoid; Q7Z6J0; -.
DR   KO; K12171; -.
DR   OMA; SSACGNS; -.
DR   OrthoDB; EOG091G09B6; -.
DR   PhylomeDB; Q7Z6J0; -.
DR   TreeFam; TF105571; -.
DR   Reactome; R-HSA-983168; Antigen processing: Ubiquitination & Proteasome degradation.
DR   SignaLink; Q7Z6J0; -.
DR   SIGNOR; Q7Z6J0; -.
DR   UniPathway; UPA00143; -.
DR   ChiTaRS; SH3RF1; human.
DR   GeneWiki; SH3RF1; -.
DR   GenomeRNAi; 57630; -.
DR   PRO; PR:Q7Z6J0; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   Bgee; ENSG00000154447; -.
DR   CleanEx; HS_SH3RF1; -.
DR   ExpressionAtlas; Q7Z6J0; baseline and differential.
DR   Genevisible; Q7Z6J0; HS.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0005794; C:Golgi apparatus; IEA:UniProtKB-SubCell.
DR   GO; GO:0030027; C:lamellipodium; IEA:UniProtKB-SubCell.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0016740; F:transferase activity; IEA:UniProtKB-KW.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0006915; P:apoptotic process; IEA:InterPro.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IMP:UniProtKB.
DR   GO; GO:0043154; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; IMP:UniProtKB.
DR   GO; GO:2001237; P:negative regulation of extrinsic apoptotic signaling pathway; IMP:UniProtKB.
DR   GO; GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway.
DR   GO; GO:0046328; P:regulation of JNK cascade; IEA:InterPro.
DR   CDD; cd00162; RING; 1.
DR   Gene3D; 3.30.40.10; -; 1.
DR   InterPro; IPR001452; SH3_domain.
DR   InterPro; IPR028502; SH3RF1.
DR   InterPro; IPR018957; Znf_C3HC4_RING-type.
DR   InterPro; IPR001841; Znf_RING.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   InterPro; IPR017907; Znf_RING_CS.
DR   PANTHER; PTHR10663:SF236; PTHR10663:SF236; 1.
DR   Pfam; PF00018; SH3_1; 1.
DR   Pfam; PF14604; SH3_9; 3.
DR   Pfam; PF00097; zf-C3HC4; 1.
DR   PRINTS; PR00452; SH3DOMAIN.
DR   SMART; SM00184; RING; 1.
DR   SMART; SM00326; SH3; 4.
DR   SUPFAM; SSF50044; SSF50044; 4.
DR   PROSITE; PS50002; SH3; 4.
DR   PROSITE; PS00518; ZF_RING_1; 1.
DR   PROSITE; PS50089; ZF_RING_2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell projection; Complete proteome; Cytoplasm;
KW   Golgi apparatus; Metal-binding; Phosphoprotein; Polymorphism;
KW   Reference proteome; Repeat; SH3 domain; Transferase; Ubl conjugation;
KW   Ubl conjugation pathway; Zinc; Zinc-finger.
FT   CHAIN         1    888       E3 ubiquitin-protein ligase SH3RF1.
FT                                /FTId=PRO_0000334151.
FT   DOMAIN      134    193       SH3 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00192}.
FT   DOMAIN      196    259       SH3 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00192}.
FT   DOMAIN      445    506       SH3 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00192}.
FT   DOMAIN      829    888       SH3 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00192}.
FT   ZN_FING      12     53       RING-type. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00175}.
FT   REGION      440    543       Interaction with AKT2. {ECO:0000250}.
FT   COMPBIAS    397    403       Poly-Pro.
FT   COMPBIAS    417    424       Poly-Ala.
FT   COMPBIAS    657    662       Poly-Ala.
FT   MOD_RES     304    304       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000269|PubMed:17535800}.
FT   MOD_RES     532    532       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     735    735       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q69ZI1}.
FT   VAR_SEQ     394    441       TLNPPLPPPPLLAATVLASTPPGATAAAAAAGMGPRPMAGS
FT                                TDQIAHL -> APPPLLLLLEWDRGPWQDPLTRLHIYGRRL
FT                                APVCMLLYIHTLLGKRIN (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_033622.
FT   VAR_SEQ     442    888       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_033623.
FT   VARIANT     663    663       P -> S (in dbSNP:rs3811813).
FT                                /FTId=VAR_043342.
FT   MUTAGEN      14     14       V->A: Loss of Ubl activity.
FT                                {ECO:0000269|PubMed:17420289}.
FT   MUTAGEN     304    304       S->A: Decreased level of phosphorylation
FT                                and no change in the ability to induce
FT                                apoptosis. {ECO:0000269|PubMed:17535800}.
FT   MUTAGEN     304    304       S->D: Decreased level of phosphorylation
FT                                and Rac-binding ability and important
FT                                loss of the ability to induce apoptosis.
FT                                {ECO:0000269|PubMed:17535800}.
FT   MUTAGEN     304    304       S->E: Decreased Rac-binding ability.
FT                                {ECO:0000269|PubMed:17535800}.
SQ   SEQUENCE   888 AA;  93129 MW;  B3018000F03D0CF1 CRC64;
     MDESALLDLL ECPVCLERLD ASAKVLPCQH TFCKRCLLGI VGSRNELRCP ECRTLVGSGV
     EELPSNILLV RLLDGIKQRP WKPGPGGGSG TNCTNALRSQ SSTVANCSSK DLQSSQGGQQ
     PRVQSWSPPV RGIPQLPCAK ALYNYEGKEP GDLKFSKGDI IILRRQVDEN WYHGEVNGIH
     GFFPTNFVQI IKPLPQPPPQ CKALYDFEVK DKEADKDCLP FAKDDVLTVI RRVDENWAEG
     MLADKIGIFP ISYVEFNSAA KQLIEWDKPP VPGVDAGECS SAAAQSSTAP KHSDTKKNTK
     KRHSFTSLTM ANKSSQASQN RHSMEISPPV LISSSNPTAA ARISELSGLS CSAPSQVHIS
     TTGLIVTPPP SSPVTTGPSF TFPSDVPYQA ALGTLNPPLP PPPLLAATVL ASTPPGATAA
     AAAAGMGPRP MAGSTDQIAH LRPQTRPSVY VAIYPYTPRK EDELELRKGE MFLVFERCQD
     GWFKGTSMHT SKIGVFPGNY VAPVTRAVTN ASQAKVPMST AGQTSRGVTM VSPSTAGGPA
     QKLQGNGVAG SPSVVPAAVV SAAHIQTSPQ AKVLLHMTGQ MTVNQARNAV RTVAAHNQER
     PTAAVTPIQV QNAAGLSPAS VGLSHHSLAS PQPAPLMPGS ATHTAAISIS RASAPLACAA
     AAPLTSPSIT SASLEAEPSG RIVTVLPGLP TSPDSASSAC GNSSATKPDK DSKKEKKGLL
     KLLSGASTKR KPRVSPPASP TLEVELGSAE LPLQGAVGPE LPPGGGHGRA GSCPVDGDGP
     VTTAVAGAAL AQDAFHRKAS SLDSAVPIAP PPRQACSSLG PVLNESRPVV CERHRVVVSY
     PPQSEAELEL KEGDIVFVHK KREDGWFKGT LQRNGKTGLF PGSFVENI
//
